The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis

HIGHLIGHTS

• who: Chunmei Zhang from the (UNIVERSITY) have published the research: The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a metau2011analysis, in the Journal: (JOURNAL) of August/10,/2021
• what: When u00adI2 > 50%, indicating that there is significant heterogeneity between the studies, and the random effects model was used; otherwise, the fixed effects model was used.
• how: The pooled result showed that angiogenesis inhibitors were significantly correlated with longer OS than control group (HR=0.88 95%CI 0.81-0.95) (Fig 4).
• future: Since only one of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.